Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 1463 entries
View as:

Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01415063 Org: User:
Start: 02/28/11 End: 03/31/14 Due: 03/31/15

Purified Anthocyanins Supplementation in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02317211 Org: User:
Start: 02/28/14 End: 09/30/14 Due: 09/30/15

Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03811379 Org: User:
Start: 11/21/18 End: 12/30/21 Due: 12/30/22

Navigation Laser Versus Traditional Laser Photocoagulation for Mild Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT03641144 Org: User:
Start: 06/01/18 End: 12/31/19 Due: 12/31/20

Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05749575 Org: User:
Start: 02/28/23 End: 08/31/24 Due: 08/31/25

Oral Nutritional Supplements Compared With Standard Diet in Postoperative Gastric Cancer Patients With Adjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03654534 Org: User:
Start: 04/16/19 End: 06/15/21 Due: 06/15/22

Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04651127 Org: User:
Start: 11/09/20 End: 09/30/23 Due: 09/30/24

Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT03969017 Org: User:
Start: 06/17/19 End: 05/30/24 Due: 05/30/25

Attention to Retinoblastoma Diagnosed in the Trauma Setting

Phase: N/A Priority: Normal
NCT ID: NCT03764930 Org: User:
Start: 01/01/13 End: 11/30/18 Due: 11/30/19

Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study

Phase: N/A Priority: Normal
NCT ID: NCT06547203 Org: User:
Start: 07/18/24 End: 07/30/29 Due: 07/30/30

DYNAMICS-LYNCH：DNA Methylation Analysis in Stool for Screening of Lynch Syndrome-Associated Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06772844 Org: User:
Start: 01/10/25 End: 12/31/28 Due: 12/31/29

Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT04680598 Org: User:
Start: 12/25/20 End: 12/31/23 Due: 12/31/24

HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC

Phase: N/A Priority: Normal
NCT ID: NCT05866172 Org: User:
Start: 05/10/23 End: 06/01/25 Due: 06/01/26

Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03700476 Org: User:
Start: 12/21/18 End: 01/31/25 Due: 01/31/26

Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations

Phase: N/A Priority: Normal
NCT ID: NCT06517953 Org: User:
Start: 07/17/24 End: 12/24/27 Due: 12/24/28

Treatment with Intensity Modulated Radiotherapy on the Change of Cognitive Function in Nasopharyngeal Carcinoma Patients: a Prospective Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT06695936 Org: User:
Start: 11/15/24 End: 11/20/28 Due: 11/20/29

Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)

Phase: N/A Priority: Normal
NCT ID: NCT06143748 Org: User:
Start: 03/02/24 End: 12/31/27 Due: 12/31/28

Outcomes of 3 Incision-size-dependent Phacoemulsification Systems

Phase: N/A Priority: Normal
NCT ID: NCT01429532 Org: User:
Start: 07/31/10 End: 05/31/11 Due: 05/31/12

SBRT Versus Ablation for Perivascular Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04434989 Org: User:
Start: 06/01/20 End: 12/01/25 Due: 12/01/26

Individualized Elective Neck Irradiation Based on MRI in NPC Patients

Phase: N/A Priority: Normal
NCT ID: NCT02642107 Org: User:
Start: 01/31/16 End: 05/31/18 Due: 05/31/19

A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC.

Phase: N/A Priority: Normal
NCT ID: NCT03210389 Org: User:
Start: 07/31/17 End: 12/31/21 Due: 12/31/22

Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers

Phase: N/A Priority: Normal
NCT ID: NCT06966232 Org: User:
Start: 05/15/25 End: 05/20/27 Due: 05/20/28

Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02887287 Org: User:
Start: 07/31/13 End: - Due: -

Regulation of Blood-Brain Barrier Permeability by APOE Gene Polymorphism and Its Impact on Cognitive Function Post-Radiotherapy in Nasopharyngeal Carcinoma: an MRI Study

Phase: N/A Priority: Normal
NCT ID: NCT06881225 Org: User:
Start: 01/01/24 End: 12/31/26 Due: 12/31/27

Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication

Phase: N/A Priority: Normal
NCT ID: NCT01894269 Org: User:
Start: 07/31/13 End: 07/31/16 Due: 07/31/17